Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial

The Lancet Infectious Diseases

Volumn 16, Issue 9, 2016, Pages 1026-1035

  Tapia, Milagritos D ^a   Sow, Samba O ^b   Tamboura, Boubou ^b   Tégueté, Ibrahima ^c   Pasetti, Marcela F ^a   Kodio, Mamoudou ^b   Onwuchekwa, Uma ^b   Tennant, Sharon M ^a   Blackwelder, William C ^a   Coulibaly, Flanon ^b   Traoré, Awa ^b   Keita, Adama Mamby ^b   Haidara, Fadima Cheick ^b   Diallo, Fatoumata ^b   Doumbia, Moussa ^b   Sanogo, Doh ^b   DeMatt, Ellen ^d   Schluterman, Nicholas H ^e   Buchwald, Andrea ^e   Kotloff, Karen L ^a   Chen, Wilbur H ^a   Orenstein, Evan W ^f,g   Orenstein, Lauren A V ^f,h   Villanueva, Julie ⁱ   Bresee, Joseph ⁱ   Treanor, John ^j   Levine, Myron M ^a   more..

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b Centre pour le Developpment des Vaccins (CVD Mali)   (Mali)

^c HÔPITAL GABRIEL TOURÉ   (Mali)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^j UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; IMMUNOLOGICAL ADJUVANT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE PAIN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALI; MATERNAL IMMUNISATION; MENINGOCOCCEMIA; MULTICENTER STUDY; NEWBORN INFECTION; PATIENT REFERRAL; PHASE 4 CLINICAL TRIAL; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIRD TRIMESTER PREGNANCY; CLINICAL TRIAL; IMMUNOLOGY; INFLUENZA, HUMAN; MORTALITY; NEWBORN; PROCEDURES; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALI; MENINGOCOCCAL VACCINES; PROSPECTIVE STUDIES; VACCINATION;

EID: 84973917450     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30054-8     Document Type: Article

References (30)

1. 1 Schanzer, DL, Langley, JM, Tam, TW, Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J Obstet Gynaecol Can 29 (2007), 622–629.
2. 2 Louie, JK, Acosta, M, Jamieson, DJ, Honein, MA, Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 362 (2010), 27–35.
3. 3 Rasmussen, SA, Jamieson, DJ, Uyeki, TM, Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 207 (2012), S3–S8.
4. 4 Pierce, M, Kurinczuk, JJ, Spark, P, Brocklehurst, P, Knight, M, Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ, 342, 2011, d3214.
5. 5 Lozano, R, Naghavi, M, Foreman, K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
6. 6 Nair, H, Brooks, WA, Katz, M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378 (2011), 1917–1930.
7. 7 O'Brien, MA, Uyeki, TM, Shay, DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 113 (2004), 585–593.
8. 8 Macias, AE, Precioso, AR, Falsey, AR, The Global Influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenza. Influenza Other Respir Viruses 9:suppl 1 (2015), 31–37.
9. 9 Lindsey, B, Kampmann, B, Jones, C, Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis 26 (2013), 248–253.
10. 10 Zaman, K, Roy, E, Arifeen, SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 (2008), 1555–1564.
11. 11 Madhi, SA, Cutland, CL, Kuwanda, L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 371 (2014), 918–931.
12. 12 Steinhoff, MC, Omer, SB, Roy, E, et al. Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial. CMAJ 184 (2012), 645–653.
13. 13 Ortiz, JR, Neuzil, KM, Ahonkhai, VI, et al. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine 30 (2012), 7134–7140.
14. 14 UNICEF. Mali statistics. 2013. at. http://www.unicef.org/infobycountry/mali_statistics.html#119 (accessed Feb 19, 2016).
15. 15 UNICEF. State of the world's children 2015: executive summary. http://www.unicef.org/publications/files/SOWC_2015_Summary_and_Tables.pdf, 2015 (accessed Feb 29, 2016).
16. 16 Sow, SO, Tapia, MD, Diallo, S, et al. Haemophilus influenzae type b conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection. Am J Trop Med Hyg 80 (2009), 1033–1038.
17. 17 Basta, NE, Borrow, R, Berthe, A, et al. Population-level persistence of immunity 2 years after the PsA-TT mass-vaccination campaign in Mali. Clin Infect Dis 61:suppl 5 (2015), S547–S553.
18. 18 WHO. Validation of neonatal tetanus elimination in Mali by lot quality-assurance cluster sampling. Wkly Epidemiol Rec 82 (2007), 309–313.
19. 19 Ballard, JL, Khoury, JC, Wedig, K, Wang, L, Eilers-Walsman, BL, Lipp, R, New Ballard Score, expanded to include extremely premature infants. J Pediatr 119 (1991), 417–423.
20. 20 WHO. Vaccines against influenza WHO position paper–November 2012. Wkly Epidemiol Rec 87 (2012), 461–476.
21. 21 Steinhoff, MC, Omer, SB, Roy, E, et al. Influenza immunization in pregnancy—antibody responses in mothers and infants. N Engl J Med 362 (2010), 1644–1646.
22. 22 Nunes, MC, Cutland, CL, Dighero, B, et al. Kinetics of hemagglutination-inhibiting antibodies following maternal influenza vaccination among mothers with and those without HIV infection and their infants. J Infect Dis 212 (2015), 1976–1987.
23. 23 Tapia, M, Sow, S, Medina-Moreno, SM, et al. A serosurvey to identify the “window of vulnerability” to wild type measles among infants in rural Mali. Am J Trop Med Hyg 73 (2005), 26–31.
24. 24 Sow, SO, Diallo, S, Campbell, JD, et al. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine. Pediatr Infect Dis J 24 (2005), 533–537.
25. 25 Keller-Stanislawski, B, Englund, JA, Kang, G, et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 32 (2014), 7057–7064.
26. 26 Lambach, P, Alvarez, AM, Hirve, S, et al. Considerations of strategies to provide influenza vaccine year round. Vaccine 33 (2015), 6493–6498.
27. 27 Cellule de Planification et de Statistique (CPS/SSDSPF) INdISIM I-S, ICF International. Enquête Démographique et de Santé au Mali 2012–2013, 2014, ICF International, Rockville, MD.
28. 28 Munoz, FM, Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?. Curr Opin Infect Dis 28 (2015), 221–224.
29. 29 Vilajeliu, A, Garcia-Basteiro, AL, Bayas, JM, Protecting newborns against pertussis: the value of vaccinating during pregnancy. Expert Rev Vaccines 14 (2015), 1051–1053.
30. 30 Roper, MH, Vandelaer, JH, Gasse, FL, Maternal and neonatal tetanus. Lancet 370 (2007), 1947–1959.